Home / NEWS & DEALS / Deals / details of junhe's deals

JunHe Recently Assisted Livzon Pharmaceutical Group in Entering an Exclusive License Agreement with Onconic to develop, License and Manufacture its Potassium-competitive acid Blocker in China

2023.03.13

On March 10, 2023, Livzon Pharmaceutical Group Inc. ("Livzon") announced that it had signed an exclusive license agreement with South Korea-based Onconic Therapeutics Inc. ("Onconic") to develop, license and manufacture its potassium-competitive acid blocker in China.  


JunHe was engaged by Livzon to draft, review, revise and negotiate the agreement and won the trust of the client for its consistently professional and efficient services.


The JunHe team was led by partner LI, Qi (Adam) with the assistance of partner ZHAO, Hao (Gerry)


JunHe is the only Chinese law firm to be admitted as a member of Lex Mundi and Multilaw, two international networks of independent law firms. JunHe and selected top law firms in major European and Asian jurisdictions are “best friends.” Through these connections, we provide high quality legal services to clients doing business throughout the world.
As the first carbon neutrality fund sponsored by a law firm in China, the BAF Carbon Neutrality Special Fund was jointly established by JunHe and the Beijing Afforestation Foundation (BAF) to promote carbon neutral initiatives, and encourage social collaboration based on the public fundraising platform to mobilize engagement in public welfare campaigns.